SAMRAT PHARMACHEM
Back to Balance Sheet
|
SAMRAT PHARMACHEM Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹50 Cr | ₹56 Cr | ₹53 Cr | ₹37 Cr | ₹27 Cr |
What is the latest Total Current Liabilities ratio of SAMRAT PHARMACHEM ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹56 Cr |
| Mar2023 | ₹53 Cr |
| Mar2022 | ₹37 Cr |
| Mar2021 | ₹27 Cr |
How is Total Current Liabilities of SAMRAT PHARMACHEM Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹50 Cr | -12.09 | |
| Mar2024 | ₹56 Cr | 6.04 | |
| Mar2023 | ₹53 Cr | 42.49 | |
| Mar2022 | ₹37 Cr | 36.60 | |
| Mar2021 | ₹27 Cr | - | |
Compare Total Current Liabilities of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹65.7 Cr | 5.1% | -11.9% | -41.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | 5.1% |
-11.9% |
-41.3% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses